Johnson & Johnson
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)
Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%
Johnson & Johnson L&D spend by Year
L&D spend — Learning & development from external providers ($M) ($M)
Johnson & Johnson L&D spend: $85M in FY2025, up 2.4% from a year earlier.
Latest, FY2025
85
Period ended Dec 28, 2025
Change on a year earlier
+2.4%
83 in FY2024
History
3 years
Since FY2023
Sources
1
J&J 2025 Health for Humanity Report
Where the FY2025 figure comes from
“Learning & development received from external providers 5 $85 $83 $85”
Source: J&J 2025 Health for Humanity Report ↗
Reported in 2025 Health for Humanity Report.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | L&D spend — Learning & development from external providers ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | 85 | +2.4% | J&J 2025 Health for Humanity Report ↗ |
| FY2024 | Dec 29, 2024 | 83 | -2.4% | J&J 2025 Health for Humanity Report ↗ |
| FY2023 | Dec 31, 2023 | 85 | – | J&J 2025 Health for Humanity Report ↗ |
Cite this data
StockData. (2026). Johnson & Johnson L&D spend ($M), annual FY2023–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/esg-ld-spend-ext
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.